Compare Stocks: TFX, STE, ZBH, and PEN

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
PEN Penumbra	$317.41 0.0%	$321.72	$221.26 ▼ $362.41	$12.50B	0.7	606,122 shs	368,271 shs
STE STERIS	$211.12 +1.2%	$224.22	$195.14 ▼ $269.44	$20.58B	0.92	768,598 shs	804,058 shs
TFX Teleflex	$125.40 +1.0%	$133.12	$100.18 ▼ $145.00	$5.31B	0.83	782,531 shs	561,636 shs
ZBH Zimmer Biomet	$91.72 +3.9%	$96.22	$79.12 ▼ $106.88	$17.49B	0.49	2.26 million shs	2.29 million shs

7 Energy Stocks to Buy and Hold Forever

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
PEN Penumbra	0.00%	-0.42%	-1.41%	-0.12%	+24.09%
STE STERIS	0.00%	-0.12%	-7.18%	-2.27%	-14.04%
TFX Teleflex	0.00%	+1.48%	-10.09%	-7.52%	-5.17%
ZBH Zimmer Biomet	0.00%	-3.00%	-9.79%	-1.56%	-12.36%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
PEN Penumbra	$317.41 0.0%	$321.72	$221.26 ▼ $362.41	$12.50B	0.7	606,122 shs	368,271 shs
STE STERIS	$211.12 +1.2%	$224.22	$195.14 ▼ $269.44	$20.58B	0.92	768,598 shs	804,058 shs
TFX Teleflex	$125.40 +1.0%	$133.12	$100.18 ▼ $145.00	$5.31B	0.83	782,531 shs	561,636 shs
ZBH Zimmer Biomet	$91.72 +3.9%	$96.22	$79.12 ▼ $106.88	$17.49B	0.49	2.26 million shs	2.29 million shs

7 Energy Stocks to Buy and Hold Forever

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
PEN Penumbra	0.00%	-0.42%	-1.41%	-0.12%	+24.09%
STE STERIS	0.00%	-0.12%	-7.18%	-2.27%	-14.04%
TFX Teleflex	0.00%	+1.48%	-10.09%	-7.52%	-5.17%
ZBH Zimmer Biomet	0.00%	-3.00%	-9.79%	-1.56%	-12.36%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
PEN Penumbra	2.18	Hold	$367.07	15.65% Upside
STE STERIS	2.75	Moderate Buy	$271.33	28.52% Upside
TFX Teleflex	2.67	Moderate Buy	$155.20	23.76% Upside
ZBH Zimmer Biomet	2.18	Hold	$103.00	12.30% Upside

Current Analyst Ratings Breakdown

Latest TFX, STE, ZBH, and PEN Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
10/5/2026	ZBH Zimmer Biomet	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Neutral
9/28/2026	ZBH Zimmer Biomet	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Market Perform
9/28/2026	TFX Teleflex	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Neutral ➝ Buy	$145.00 ➝ $158.00
9/24/2026	TFX Teleflex	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold ➝ Strong-Buy
9/21/2026	TFX Teleflex	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D)
9/14/2026	ZBH Zimmer Biomet	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold (C-) ➝ Hold (C)
8/25/2026	TFX Teleflex	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$159.00 ➝ $170.00
8/25/2026	ZBH Zimmer Biomet	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Strong Sell ➝ Hold
8/24/2026	STE STERIS	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Hold (C)
8/24/2026	PEN Penumbra	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Strong Sell ➝ Hold
8/11/2026	TFX Teleflex	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Neutral	$145.00 ➝ $158.00

(Data available from 10/5/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
PEN Penumbra	$1.40B	8.91	$4.30 per share	73.87	$36.45 per share	8.71
STE STERIS	$5.94B	3.47	$15.38 per share	13.73	$73.39 per share	2.88
TFX Teleflex	$1.99B	2.67	$11.31 per share	11.09	$70.71 per share	1.77
ZBH Zimmer Biomet	$8.23B	2.13	$14.26 per share	6.43	$64.11 per share	1.43

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
PEN Penumbra	$177.69M	$4.07	77.99	51.86	2.18	10.67%	10.50%	8.17%	11/4/2026 (Estimated)
STE STERIS	$782.30M	$8.18	25.81	17.22	N/A	13.34%	14.34%	9.66%	11/4/2026 (Estimated)
TFX Teleflex	-$905.64M	-$23.29	N/A	11.52	0.83	-39.67%	11.93%	5.44%	11/5/2026 (Estimated)
ZBH Zimmer Biomet	$705.20M	$4.11	22.32	10.20	1.67	9.48%	13.12%	7.23%	11/4/2026 (Estimated)

Latest TFX, STE, ZBH, and PEN Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/6/2026	Q2 2026	TFX Teleflex	$1.28	$1.76	+$0.48	$2.28	$559.59 million	$570.33 million
8/5/2026	Q1 2027	STE STERIS	$2.49	$2.59	+$0.10	$2.04	$1.49 billion	$1.49 billion
8/5/2026	Q2 2026	ZBH Zimmer Biomet	$2.01	$2.07	+$0.06	$1.03	$2.13 billion	$2.18 billion
7/30/2026	Q2 2026	PEN Penumbra	$1.16	$0.88	-$0.28	$0.88	$389.64 million	$390.05 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
PEN Penumbra	N/A	N/A	N/A	N/A	N/A
STE STERIS	$2.76	1.32%	+9.40%	33.74%	20 Years
TFX Teleflex	$1.36	1.08%	N/A	N/A	N/A
ZBH Zimmer Biomet	$0.96	1.06%	N/A	23.36%	N/A

Latest TFX, STE, ZBH, and PEN Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
8/28/2026	ZBH Zimmer Biomet	quarterly	$0.24	1.08%	9/30/2026	9/30/2026	10/30/2026
8/4/2026	TFX Teleflex	quarterly	$0.34	0.99%	8/14/2026	8/14/2026	9/30/2026
7/30/2026	STE STERIS	quarterly	$0.69	1.23%	9/4/2026	9/4/2026	9/25/2026

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
PEN Penumbra	0.01	5.75	3.86
STE STERIS	0.23	1.91	1.35
TFX Teleflex	0.94	2.60	2.12
ZBH Zimmer Biomet	0.50	1.69	0.94

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
PEN Penumbra	88.88%
STE STERIS	94.69%
TFX Teleflex	95.62%
ZBH Zimmer Biomet	88.89%

Insider Ownership

Company	Insider Ownership
PEN Penumbra	2.90%
STE STERIS	1.12%
TFX Teleflex	0.70%
ZBH Zimmer Biomet	1.28%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
PEN Penumbra	4,700	39.39 million	38.25 million	Optionable
STE STERIS	17,937	97.50 million	96.41 million	Optionable
TFX Teleflex	15,500	42.37 million	42.08 million	Optionable
ZBH Zimmer Biomet	17,000	190.74 million	188.30 million	Optionable

TFX, STE, ZBH, and PEN Headlines

Recent News About These Companies

RBC Capital Reaffirms Their Buy Rating on Zimmer Biomet Holdings (ZBH)

October 4 at 1:29 AM | theglobeandmail.com

Consensus price target for Zimmer Biomet Holdings increases 21.22% to MX$2,012.42

October 2 at 1:30 PM | msn.com

What Changed for Zimmer Biomet (NYSE:ZBH) After Dividend Update?

September 30, 2026 | kalkinemedia.comK

Financial Review: Zimmer Biomet (NYSE:ZBH) versus Owlet (NYSE:OWLT)

September 29, 2026 | americanbankingnews.com

Zimmer Biomet Holdings, Inc. $ZBH Holdings Lifted by Envestnet Asset Management Inc.

September 29, 2026 | marketbeat.com

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Shares Set to Pay Quarterly Dividend of $0.24

September 28, 2026 | americanbankingnews.com

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Shareholders to Get $0.24 Quarterly Dividend

September 28, 2026 | marketbeat.com

Zimmer Biomet (ZBH): Buy, sell, or hold post Q2 earnings?

September 25, 2026 | msn.com

Zimmer Biomet Holdings (ZBH) Pushes Cost Reset Plans, Is It Still 17% Below Fair Value?

September 25, 2026 | finance.yahoo.com

Zimmer Biomet Holdings, Inc. $ZBH Holdings Lifted by State Street Corp

September 24, 2026 | marketbeat.com

Surgery Partners, 10x Genomics, QuidelOrtho, Zimmer Biomet, and Tandem Diabetes stocks trade down, what you need to know

September 23, 2026 | msn.com

Nykredit A S Takes $3.22 Million Position in Zimmer Biomet Holdings, Inc. $ZBH

September 23, 2026 | marketbeat.com

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Given Average Recommendation of "Hold" by Brokerages

September 22, 2026 | marketbeat.com

What Is Behind the New Interest in Zimmer Biomet (ZBH)?

September 18, 2026 | kalkinemedia.comK

Zimmer Biomet to Showcase Complete Shoulder Solution Designed to Support Surgeon Flexibility

September 18, 2026 | orthospinenews.comO

2,177,724 Shares in Zimmer Biomet Holdings, Inc. $ZBH Purchased by Bank of America Corp DE

September 18, 2026 | marketbeat.com

Here's Why Zimmer Biomet (ZBH) is a Strong Value Stock

September 17, 2026 | zacks.com

Zimmer Biomet ‘Restructuring’ Plan Involves 580 Cut Jobs

September 16, 2026 | mddionline.comM

Is Zimmer Biomet stock underperforming the Nasdaq?

September 16, 2026 | msn.com

Zimmer Biomet (NYSE:ZBH) Insider Sells $528,978.45 in Stock

September 15, 2026 | marketbeat.com

How Zimmer Biomet’s New Americas and Robotics Leadership Structure At Zimmer Biomet Holdings (ZBH) Has Changed Its Investment Story

September 14, 2026 | finance.yahoo.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

TFX, STE, ZBH, and PEN Company Descriptions

Penumbra NYSE:PEN

$317.41 -0.14 (-0.04%)

Closing price 03:59 PM Eastern

Extended Trading

$315.23 -2.18 (-0.69%)

As of 07:30 PM Eastern

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX Select, BENCHMARK, BMX96, BMX81, DDC, SENDit, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization Device, aspiration tubing, and aspiration pump under the Penumbra RED, JET, ACE, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that includes the Penumbra Coil 400, a detachable coil that provides an alternative for the treatment of aneurysms and other complex lesions, as well as Penumbra SMART COIL, a detachable coil to treat patients with a wide range of neurovascular lesions; and POD400 and PAC400 brands. In addition, the company provides peripheral embolization products, such as Ruby Coil System consisting of detachable coils for peripheral applications; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers an immersive 3D computer-based technology platform under the real immersive system brand; and neurosurgical tools, such as Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.

STERIS NYSE:STE

$211.12 +2.58 (+1.24%)

Closing price 03:59 PM Eastern

Extended Trading

$211.20 +0.07 (+0.03%)

As of 07:30 PM Eastern

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier, sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The Dental segment provides hand and electric-powered dental instruments, infection control products, conscious sedation, personal protective equipment, and water quality products for dental suite. The company serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is based in Dublin, Ireland.

Teleflex NYSE:TFX

$125.40 +1.28 (+1.03%)

Closing price 03:59 PM Eastern

Extended Trading

$125.27 -0.13 (-0.10%)

As of 07:30 PM Eastern

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. It also offers interventional products, which consists of various coronary catheters, structural heart support devices, and peripheral intervention and mechanical circulatory support platform that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded pumps and catheters, Guideline, Turnpike, and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. The company provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. It also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings; urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. Teleflex Incorporated was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.

Zimmer Biomet NYSE:ZBH

$91.72 +3.43 (+3.89%)

Closing price 03:59 PM Eastern

Extended Trading

$91.17 -0.55 (-0.60%)

As of 07:30 PM Eastern

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers robotic, surgical, and bone cement products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest TFX, STE, ZBH, and PEN Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest TFX, STE, ZBH, and PEN Earnings

Compare Dividends

Latest TFX, STE, ZBH, and PEN Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

TFX, STE, ZBH, and PEN Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

TFX, STE, ZBH, and PEN Company Descriptions

Penumbra NYSE:PEN

STERIS NYSE:STE

Teleflex NYSE:TFX

Zimmer Biomet NYSE:ZBH

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools